Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $3.5 million.

  • Prime Medicine's Treasury Shares changed 0.01% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year change of 0.01%. This contributed to the annual value of $3.5 million for FY2024, which is 939.85% down from last year.
  • As of Q3 2025, Prime Medicine's Treasury Shares stood at $3.5 million, which was up 0.01% from $3.5 million recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Treasury Shares peaked at $10.8 million during Q4 2021, and registered a low of $3116.0 during Q2 2022.
  • Over the past 5 years, Prime Medicine's median Treasury Shares value was $3.5 million (recorded in 2024), while the average stood at $3.5 million.
  • As far as peak fluctuations go, Prime Medicine's Treasury Shares tumbled by 5586.77% in 2022, and later surged by 12290285.62% in 2023.
  • Prime Medicine's Treasury Shares (Quarter) stood at $10.8 million in 2021, then plummeted by 53.57% to $5.0 million in 2022, then decreased by 23.57% to $3.8 million in 2023, then decreased by 9.4% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
  • Its Treasury Shares stands at $3.5 million for Q3 2025, versus $3.5 million for Q2 2025 and $3.5 million for Q1 2025.